RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 129 filers reported holding RECURSION PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,590 | -99.9% | 882,129 | -41.6% | 0.65% | -38.8% |
| Q1 2023 | $10,066,724 | -13.5% | 1,509,254 | 0.0% | 1.06% | -26.7% |
| Q4 2022 | $11,636,348 | -27.5% | 1,509,254 | 0.0% | 1.44% | -27.8% |
| Q3 2022 | $16,058,000 | +30.7% | 1,509,254 | 0.0% | 2.00% | +40.5% |
| Q2 2022 | $12,285,000 | +13.7% | 1,509,254 | 0.0% | 1.42% | +30.3% |
| Q1 2022 | $10,806,000 | -58.2% | 1,509,254 | 0.0% | 1.09% | -55.0% |
| Q4 2021 | $25,854,000 | -25.6% | 1,509,254 | 0.0% | 2.43% | +19.3% |
| Q3 2021 | $34,728,000 | -37.0% | 1,509,254 | 0.0% | 2.04% | -35.8% |
| Q2 2021 | $55,088,000 | – | 1,509,254 | – | 3.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Data Collective IV GP, LLC | 5,941,120 | $45,806,035 | 48.11% |
| Kinnevik AB (publ) | 7,653,061 | $59,005,100 | 33.28% |
| MV Management XI, L.L.C. | 1,971,908 | $15,203,411 | 26.45% |
| MIC Capital Management UK LLP | 8,451,758 | $65,163,057 | 12.86% |
| ArchPoint Investors | 1,114,626 | $8,593,766 | 4.07% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $11,636,348 | 1.44% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,710,339 | $20,896,714 | 0.80% |
| Duquesne Family Office | 1,385,950 | $10,685,675 | 0.53% |
| ALLEN OPERATIONS LLC | 217,657 | $1,678,135 | 0.45% |
| Artal Group S.A. | 960,204 | $7,403 | 0.41% |